Study of the Intradermal Injection of rHuPH20 or Placebo in Participants With Nickel Allergic Contact Dermatitis
Clinical trial NCT00928447 · COMPLETED
Trial details
- NCT number
- NCT00928447
- Sponsor
- Halozyme Therapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-06-23
- Primary completion
- 2009-09-13
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.